MaddenT, SecuraGM, NeaseRF, PolitiMC, PeipertJF. The role of contraceptive attributes in women's contraceptive decision making. Am J Obstet Gynecol, 2015; 213:46.e1–e6.
2.
Centers for Disease Control and Prevention.. Condom fact sheet in brief. Available at: https://www.cdc.gov/condomeffectiveness/brief.html Accessed February19, 2018.
3.
HunterLA, NelsonL, ChowJM, HoltBY, BauerHM. Contraceptive method use and chlamydia positivity among California family planning clients: The case for new multipurpose prevention technologies (MPTs). J Womens Health (Larchmt), 2018; 27:768–774.
4.
DickerLW, MosureDJ, LevineWC. Chlamydia positivity versus prevalence. What's the difference?. Sex Transm Dis, 1998; 25:251–253.
WilliamsRL, FortenberryJD. Dual use of long-acting reversible contraceptives and condoms among adolecents. J Adolesc Health, 2013; 52:S29–S34.
7.
Lusti-NarasimhanM, KhoslaR, TemmermanM, Young HoltB. Advancing the sexual and reproductive health and human rights of women beyond 2015. BJOG, 2014; 121:1–2.
8.
TrusselJ. Contraceptive failure in the United States. Contraception, 2011; 83:397–404.
